2021
DOI: 10.1007/s00604-021-05033-3
|View full text |Cite
|
Sign up to set email alerts
|

Point-of-care testing of butyrylcholinesterase activity through modulating the photothermal effect of cuprous oxide nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…It is an essential indicator for the prediction and diagnosis of many diseases, including liver damage, Alzheimer's disease, and organophosphorus pesticide (OP) poisoning. 1 Therefore, accurate determination of BChE's activity has practical significance. So far, colorimetric and fluorescence methods were most commonly used in the evaluation of BChE's activity.…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is an essential indicator for the prediction and diagnosis of many diseases, including liver damage, Alzheimer's disease, and organophosphorus pesticide (OP) poisoning. 1 Therefore, accurate determination of BChE's activity has practical significance. So far, colorimetric and fluorescence methods were most commonly used in the evaluation of BChE's activity.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Butyrylcholinesterase (BChE) is a nonspecific cholinesterase that can hydrolyze a variety of choline esters. It is an essential indicator for the prediction and diagnosis of many diseases, including liver damage, Alzheimer’s disease, and organophosphorus pesticide (OP) poisoning . Therefore, accurate determination of BChE’s activity has practical significance.…”
Section: Introductionmentioning
confidence: 99%
“…Butyrylcholinesterase (BChE) is an important member of cholinesterases, which is produced by hepatocytes in liver and released into blood plasma for catalyzing the hydrolysis of choline-based esters. [1][2][3] Liver diseases, such as hepatic cirrhosis, hepatocellular carcinoma, and acute hepatitis, can reduce the production of BChE in the liver, thus leading to a low level of BChE activity in the bloodstream. [4][5][6] Accordingly, BChE activity is one of the most vital bioindicators in the clinical diagnosis of liver diseases.…”
Section: Introductionmentioning
confidence: 99%